BIVI

BioVie Inc.

1.77 USD
-0.12 (-6.35%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

BioVie Inc. stock is up 65.42% since 30 days ago. The next earnings date is May 10, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 9 March’s closed higher than February. In the last 8 Unusual Options Trades, there were 3 PUTs, 5 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
05 Jan 17:01 19 Jan, 2024 2.50 PUT 222 7716
05 Jan 17:02 19 Jan, 2024 2.50 PUT 208 7716
12 Jan 20:59 19 Jan, 2024 2.50 PUT 500 7498
01 Mar 15:31 15 Mar, 2024 2.50 CALL 658 0
01 Mar 15:32 15 Mar, 2024 2.50 CALL 9361 0
01 Mar 15:59 15 Mar, 2024 2.00 CALL 9848 0
01 Mar 19:10 15 Mar, 2024 1.00 CALL 250 10
01 Mar 20:40 15 Mar, 2024 2.00 CALL 9099 0

About BioVie Inc.

BioVie Inc. engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trials for Alzheimer's, Parkinson's and multiple myeloma and prostate cancer.